Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Q3 2024 Zydus Lifesciences Ltd Earnings Call Transcript

Feb 09, 2024 / 10:00AM GMT
Release Date Price: ₹805.6 (+0.47%)
Operator

Welcome to Zydus Lifesciences Limited Q3 FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ganesh Nayak, Executive Director of Zydus Lifesciences. Thank you, and over to you, sir.

Ganesh Nayak
Zydus Lifesciences Ltd - Executive Director

Good afternoon, ladies and gentlemen. Welcome to our post-results teleconference for the quarter ended December 31, 2023. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Arvind Bothra, Senior Vice President, Investor Relations; and Mr. Alok Garg, Senior Vice President from the Managing Director's Office.

Let me now give you a broad overview of the developments during the quarter. We are happy to end the calendar year with a strong performance and expect to sustain the growth momentum going ahead. The quarter gone by was an encouraging one for our India formulations business.

The business delivered strong double-digit growth during the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot